Eye Scan and AFib: Can a Routine Eye Test Spot Atrial Fibrillation Years Early?
Updated: 2 days ago
Written and medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: September 2026
A new study of more than 89,000 people found that a thin layer of nerve tissue at the back of the eye was measurably thinner in people with atrial fibrillation — the most common irregular heart rhythm — and was already thinner, on average, about four years before those people were diagnosed. The research was published in September 2026 in PLOS Digital Health. It does not mean an eye test can diagnose a heart condition today. It does suggest that routine eye scans might one day help flag who needs their heart rhythm checked. Here is what the link between an eye scan and AFib (atrial fibrillation) really means for you.
Key takeaways
Researchers at UCL and Moorfields Eye Hospital analysed retinal scans from nearly 90,000 people across two large UK datasets.
People with atrial fibrillation had a thinner macular ganglion cell–inner plexiform layer (mGCIPL) — a nerve layer inside the retina.
Among people who had no diagnosis at the time of their scan, those who went on to develop atrial fibrillation already showed thinning roughly four years earlier.
This is an observational finding. It shows an association, not a cause, and it is not a replacement for an ECG.
The practical takeaway today is simpler than the headline: know the symptoms of atrial fibrillation, and get a pulse or rhythm check if you have them.
What is atrial fibrillation?
Atrial fibrillation is a heart rhythm disorder in which the upper chambers of the heart quiver instead of beating in a steady, coordinated way. The result is an irregular — and often fast — heartbeat.
The reason doctors care so much about it is not the rhythm itself. It is that blood can pool and clot in a quivering chamber, and if a clot travels to the brain it causes a stroke. Atrial fibrillation substantially raises stroke risk, and strokes caused by it tend to be more severe than other strokes.
The difficulty is that many people feel nothing at all. Others notice palpitations, breathlessness, unusual tiredness, dizziness or chest discomfort — but symptoms often come and go, which is exactly why the condition is so often found late, sometimes only after a stroke has already happened.
What did the new study actually do?
The team, led by Dr Josef Huemer and Dr Siegfried Wagner at the UCL Institute of Ophthalmology and Moorfields Eye Hospital NHS Foundation Trust, looked at retinal images taken with optical coherence tomography (OCT) — the scan many people already receive at a routine optician appointment or eye clinic. OCT produces a cross-section of the retina, letting clinicians measure individual layers in microscopic detail.
They analysed two separate groups of people:
AlzEye — a dataset of 50,651 patients seen at Moorfields Eye Hospital, of whom 5,375 had atrial fibrillation.
UK Biobank — a research cohort of 39,013 participants who had retinal imaging and no atrial fibrillation at the start; 838 were diagnosed over an average of four years of follow-up.
In both groups, people with atrial fibrillation had a thinner mGCIPL than people without it. The researchers then looked specifically at people who had no atrial fibrillation diagnosis when their eye scan was taken. Among those who were later diagnosed, the thinning was already visible roughly four years before they presented to hospital — and it remained detectable after the researchers accounted for age, sex, ethnicity, high blood pressure, diabetes, smoking and alcohol use.
"Retinal imaging could act as a complementary tool, catching those most at risk of atrial fibrillation before it causes real harm." — Dr Siegfried Wagner, senior author, UCL Institute of Ophthalmology and Moorfields Eye Hospital NHS Foundation Trust
Why would a heart rhythm problem show up in the eye?
The retina is the only place in the body where blood vessels and nerve tissue can be photographed directly, without surgery. This is the basis of a field researchers call oculomics — using eye images to detect signals about the rest of the body.
The leading explanation for this particular finding is blood supply. Atrial fibrillation reduces the efficiency of the heart's pumping and can cause small, repeated interruptions in blood flow. Nerve tissue is highly sensitive to that. Over years, reduced or unstable perfusion may cause the retina's nerve layer to thin — a visible trace of a circulation problem elsewhere.
This mechanism is plausible but was not proven by this study. The research measured an association between retinal thickness and later diagnosis; it did not demonstrate that the heart rhythm caused the thinning.
Eye scan and AFib: can an eye test diagnose it?
No. Not now, and possibly not ever on its own. Three limits matter:
It is observational. The study compared groups of people and followed what happened. It cannot establish cause, and it cannot rule out that some third factor explains both the thinning and the heart condition.
A thin retinal layer is not specific to AFib. Thinning of the same layer has been studied in glaucoma, diabetes, multiple sclerosis and dementia. On its own it does not point to the heart.
The authors say so directly. They describe retinal imaging as a possible complementary screening signal, not a substitute for ECG-based diagnosis.
How this compares with the tests that actually diagnose AFib
Method | What it does | Status today |
|---|---|---|
Electrocardiogram (ECG) | Records the heart's electrical activity; confirms the rhythm | The diagnostic standard |
Ambulatory monitor (Holter, patch) | Records rhythm over days to weeks to catch intermittent episodes | Standard where AFib comes and goes |
Consumer smartwatch / smartphone ECG | Flags possible irregular rhythm for follow-up | Screening aid only; needs clinical confirmation |
Manual pulse check | Feels for an irregular pulse | Free, fast, no equipment — findings must be confirmed |
Retinal OCT scan | Measures retinal nerve layer thickness | Research stage only — not a diagnostic test for AFib |
What should you actually do with this information?
Learn the symptoms. Palpitations or a fluttering heartbeat, breathlessness, unexplained fatigue, dizziness, fainting or chest discomfort are worth raising with a doctor — particularly if they come and go.
Check your pulse occasionally. Place two fingers on the inside of your wrist for 30 seconds. An irregular, erratic rhythm is worth mentioning to a clinician. This is not a diagnosis, only a prompt.
Don't ignore a smartwatch alert. If a wearable flags a possible irregular rhythm, treat it as a reason to seek a proper ECG, not as a verdict either way.
Keep your eye appointments. Not because they screen for heart disease — they don't — but because eye scans already detect a great deal, and this research is a reason to expect they may detect more over time.
Manage the risk factors you can. High blood pressure, excess alcohol, obesity, untreated sleep apnoea and inactivity are all associated with higher atrial fibrillation risk, and are worth addressing regardless of what any eye scan shows.
Frequently asked questions
Can an optician detect heart disease?
Not currently. Opticians are not testing for heart conditions, and no eye test is approved to diagnose atrial fibrillation. This research suggests retinal scans carry signals related to cardiovascular health, but turning that into a usable screening tool would require further studies and regulatory approval.
What is the mGCIPL?
The macular ganglion cell–inner plexiform layer is a thin layer of nerve cells and their connections inside the retina, at the back of the eye. It can be measured precisely with an OCT scan. Thinning of this layer is studied as a marker in several conditions, including glaucoma and dementia.
Is atrial fibrillation dangerous if I feel fine?
It can be. Many people have no symptoms, yet the raised stroke risk still applies. That is precisely why early detection matters and why researchers are looking for new ways to identify people before a first serious event.
How reliable is this study?
It is large and used two independent datasets, which strengthens it. But it is observational, both cohorts are UK-based, and UK Biobank participants are known to be healthier and less ethnically diverse than the general population — so the findings may not transfer equally to all groups.
Health information, not medical advice. This article summarises published research for general education. It is not a diagnosis, a treatment recommendation, or a substitute for care from a qualified clinician who knows your history. If you have symptoms of an irregular heartbeat, or you are worried about your heart, speak to a doctor. If you have chest pain, severe breathlessness, or symptoms of a stroke — face drooping, arm weakness, or speech difficulty — seek emergency care immediately.
Sources
Huemer J, Wagner SK, et al. "Atrial fibrillation and retinal imaging-based oculomics: A cross-sectional and longitudinal analysis of two large cohorts." PLOS Digital Health 5(9):e0001661, September 2026. doi.org/10.1371/journal.pdig.0001661
UCL / Moorfields Eye Hospital NHS Foundation Trust research announcement, 14 September 2026. eurekalert.org/news-releases/1143907
About the author: Dr. Baraa Alnahhal, MD, is a medical doctor and the founder of Rinnit. Dr. Baraa Alnahhal reviews new medical research and translates it into clear, evidence-based health information for everyday readers.
Comments